UK
UK
Oct-17
Mental Health Neurology Paediatrics Pharmacoepidemiology
Read moreOct-17
Endocrinology Musculoskeletal Pharmacoepidemiology
Read moreOct-17
Musculoskeletal Pharmacoepidemiology
Read moreOct-17
Endocrinology General Analysis Pharmacoepidemiology
Read moreSep-17
Pharmacoepidemiology Respiratory
Read moreSep-17
Cardiovascular Pharmacoepidemiology
Read moreSep-17
Gastroenterology Oncology Pharmacoepidemiology
Read moreSep-17
Cardiovascular Pharmacoepidemiology
Read moreSep-17
Endocrinology Pharmacoepidemiology
Read moreAug-17
Cardiovascular Endocrinology Pharmacoepidemiology
Read moreAug-17
Aug-17
Other Vascular Pharmacoepidemiology
Read more| Date | Title | Categories | |
|---|---|---|---|
| Oct-17 | A multi-national comparison of antipsychotic drug use in children and adolescents, 2005–2012 | Read more | |
| Oct-17 | Effect of Anti-Diabetic Medications on Fracture Risk in Type II Diabetes Mellitus | Read more | |
| Oct-17 | Effect of Initiating Metformin Vs. Sulfonylureas on the Risk of Total Knee Arthroplasty | Read more | |
| Oct-17 | Implementation of Nice Guidance for the Treatment of Type 2 Diabetes | Read more | |
| Sep-17 | Epidemiology of pneumothorax: UK national primary care data (1995-2015) | Read more | |
| Sep-17 | Hospitalisation for heart failure and death in new users of SGLT-2 inhibitors in patients with and without cardiovascular disease: the CVD-REAL study | Read more | |
| Sep-17 | New use of low-dose aspirin and risk of colorectal cancer by stage at diagnosis: a nested case-control study in UK general practice | Read more | |
| Sep-17 | The role of contraindications in prescribing anticoagulants to patients with atrial fibrillation: a cross-sectional analysis of primary care data in the UK | Read more | |
| Sep-17 | Treatment failure with sitagliptin compared to sulphonylureas for type 2 diabetes inadequately controlled on metformin | Read more | |
| Aug-17 | Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study | Read more | |
| Aug-17 | Impact of Risk Minimisation Measures on the Use of Strontium Ranelate: A Multi‐National Cohort Study in 5 EU Countries by the EU‐ADR Alliance | Read more | |
| Aug-17 | Impact of Risk Minimization Measures on the Use of Cilostazol in Europe | Read more |
